Issued Patents 2025
Showing 1–15 of 15 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12416635 | Live cell imaging systems and methods to validate triggering of immune response | Shahrooz Rabizadeh, Nicholas J. Witchey | 2025-09-16 |
| 12412639 | Method of characterizing a tumor based on an immune gene expression signature in regulatory T cell (Treg)-enriched tumor samples | Kevin B. Givechian, Kamil Wnuk, Chad Garner, Stephen Charles Benz, Hermes J. Garban +2 more | 2025-09-09 |
| 12397019 | Mesenchymal stem cell derived exosomes and methods | Patrick Soon-Shiong, Francesco Curcio | 2025-08-26 |
| 12385903 | RP182 compositions and methods | Patrick Soon-Shiong | 2025-08-12 |
| 12350323 | Cellular adjuvants for viral infection | Raymond S. Wong, Peter Sieling, Philip T. Liu | 2025-07-08 |
| 12329809 | Cellular adjuvants for viral infection | Raymond S. Wong, Peter Sieling, Philip T. Liu | 2025-06-17 |
| 12311018 | Targeted neoepitope vectors and methods therefor | — | 2025-05-27 |
| 12303477 | HIV treatment compositions and methods | Jeffrey Safrit, John H. Lee | 2025-05-20 |
| 12308095 | Prediction of computational pathway circuits | Clifford Anders Olson, Nicholas J. Witchey, Wael Tadros | 2025-05-20 |
| 12290558 | SARS-CoV-2 vaccines comprising human adenovirus vectors encoding spike and nucleocapsid-ETSD immunogens | Patrick Soon-Shiong, Peter Sieling, Shahrooz Rabizadeh, Lise Geissert, Annie Shin +4 more | 2025-05-06 |
| 12285481 | Methods for the treatment of COVID-19 comprising administering replication-defective adenoviruses encoding the SARS-CoV-2 spike glycoprotein and modified nucleocapsid protein | Thomas H. King | 2025-04-29 |
| 12280092 | Reprogrammed T cell-like NK cells | — | 2025-04-22 |
| 12263189 | Mesenchymal stem cell derived exosomes and methods | Patrick Soon-Shiong, Francesco Curcio | 2025-04-01 |
| 12247086 | Enhanced immunogenicity for GPI-anchored antigens | Wael Tadros, Annie Shin | 2025-03-11 |
| 12220452 | Cellular adjuvants for viral infection | Raymond S. Wong, Peter Sieling, Philip T. Liu | 2025-02-11 |